Rankings
▼
Calendar
CMPX FY 2018 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CMPX
Compass Therapeutics, Inc.
$764M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2M
Operating Income
-$38M
Net Income
-$38M
EPS (Diluted)
$-7.66
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$36M
Stock-Based Comp.
$656,000
Balance Sheet
Total Assets
$65M
Total Liabilities
$149M
Stockholders' Equity
-$85M
Cash & Equivalents
$58M
← Q2 2018
All Quarters